Purple Share Price
NASDAQ: PPBT | Others$0.00
+0.00 (0.00%) Purple Stock Performance
Purple Share Price Chart
$0.00$0.00
L
H
Corporate Actions
About Purple
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
Purple Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.20 | $1.59 | +44.55% |
Oct 2026 | $1.48 | $1.10 | -24.14% |
Sep 2026 | $1.48 | $1.45 | -14.71% |
Aug 2026 | $1.44 | $1.70 | +18.88% |
Jul 2026 | $1.71 | $1.43 | -15.63% |
Jun 2026 | $2.13 | $1.70 | -41.45% |
May 2026 | $3.83 | $2.90 | -33.14% |
Apr 2026 | $4.25 | $4.33 | +10.60% |
Mar 2026 | $4.72 | $3.92 | +785.75% |
Feb 2026 | $0.57 | $0.44 | -23.79% |
Jan 2026 | $0.70 | $0.58 | -9.94% |
Dec 2025 | $0.81 | $0.64 | -19.70% |